Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (241-250 of 330) with videos related to

Pageof 33
Sort By:
Lancet (London, England)|September 27, 2003
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trialJens Overgaard, Hanne Sand Hansen, Lena Specht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast CancerLise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Hella Danø, et al.
Acta Oncologica (Stockholm, Sweden)|January 3, 2025
The clinical utility of circulating human papillomavirus across squamous cell carcinomasKaren-Lise G Spindler, Anne V Jakobsen, Jesper G Eriksen, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2013
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Kenneth Jensen, et al.
Breast Cancer Research and Treatment|August 8, 2020
Patterns in detection of recurrence among patients treated for breast cancerLena Saltbæk, Trine Allerslev Horsboel, Birgitte Vrou Offersen, et al.
Cancer Epidemiology|August 19, 2014
Completeness and validity in a national clinical thyroid cancer database: DATHYRCAStefano Christian Londero, Jes Sloth Mathiesen, Annelise Krogdahl, et al.
Breast (Edinburgh, Scotland)|October 3, 2025
Beyond the first cut: Impact of repeat surgery versus boost on breast induration-A post hoc analysis from the DBCG HYPO & PBI trialsKristine Wiborg Høgsbjerg, Else Maae, Mette Holck Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative GroupAnn S Knoop, Helle Knudsen, Eva Balslev, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2005
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyMarianne Nordsmark, Søren M Bentzen, Volker Rudat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2015
The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell typesBrita Singers Sørensen, Anders Knudsen, Catja Foged Wittrup, et al.
Pageof 33

Showing results (241-250 of 330) with videos related to

Sort By:
Pageof 33
Lancet (London, England)|September 27, 2003
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trialJens Overgaard, Hanne Sand Hansen, Lena Specht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast CancerLise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Hella Danø, et al.
Acta Oncologica (Stockholm, Sweden)|January 3, 2025
The clinical utility of circulating human papillomavirus across squamous cell carcinomasKaren-Lise G Spindler, Anne V Jakobsen, Jesper G Eriksen, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2013
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Kenneth Jensen, et al.
Breast Cancer Research and Treatment|August 8, 2020
Patterns in detection of recurrence among patients treated for breast cancerLena Saltbæk, Trine Allerslev Horsboel, Birgitte Vrou Offersen, et al.
Cancer Epidemiology|August 19, 2014
Completeness and validity in a national clinical thyroid cancer database: DATHYRCAStefano Christian Londero, Jes Sloth Mathiesen, Annelise Krogdahl, et al.
Breast (Edinburgh, Scotland)|October 3, 2025
Beyond the first cut: Impact of repeat surgery versus boost on breast induration-A post hoc analysis from the DBCG HYPO & PBI trialsKristine Wiborg Høgsbjerg, Else Maae, Mette Holck Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative GroupAnn S Knoop, Helle Knudsen, Eva Balslev, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2005
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyMarianne Nordsmark, Søren M Bentzen, Volker Rudat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2015
The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell typesBrita Singers Sørensen, Anders Knudsen, Catja Foged Wittrup, et al.
Pageof 33